Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,181 | -10,278 | 111,997 | -172,415 | -183,524 |
| Depreciation Amortization | 509 | 922 | 1,193 | 736 | 4,067 |
| Accounts receivable | N/A | N/A | N/A | N/A | -8,224 |
| Accounts payable and accrued liabilities | 231 | -2,135 | -1,211 | -1,062 | 1,887 |
| Other Working Capital | 1,660 | -17,446 | -4,086 | 4,591 | 3,864 |
| Other Operating Activity | 951 | 5,856 | -98,534 | 113,017 | 22,459 |
| Operating Cash Flow | $1,170 | $-23,081 | $9,359 | $-55,133 | $-159,471 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -34 | -207 |
| Purchase Sale Intangibles | N/A | N/A | -355 | -2,189 | -1,391 |
| Other Investing Activity | 0 | 0 | -355 | -2,189 | -1,391 |
| Investing Cash Flow | $N/A | $N/A | $-355 | $-2,223 | $-1,598 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 50,000 |
| Common Stock Issued | 0 | 3,151 | 2,468 | 184,670 | 31,975 |
| Other Financing Activity | 0 | 0 | -237,674 | -55,118 | -1,250 |
| Financing Cash Flow | $0 | $3,151 | $-235,206 | $129,552 | $80,725 |
| Beginning Cash Position | 4,327 | 49,317 | 65,122 | 80,486 | 160,830 |
| End Cash Position | 5,059 | 4,327 | 49,317 | 65,122 | 80,486 |
| Net Cash Flow | $732 | $-44,990 | $-15,805 | $-15,364 | $-80,344 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,170 | -23,081 | 9,359 | -55,133 | -159,471 |
| Capital Expenditure | N/A | N/A | N/A | -34 | -207 |
| Free Cash Flow | 1,170 | -23,081 | 9,359 | -55,167 | -159,678 |